Patents by Inventor Michael Leviten

Michael Leviten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-complement factor C1q Fab fragments and uses thereof
    Patent number: 11999779
    Abstract: The present disclosure relates generally to anti-C1q antibody Fab fragments and methods of using the same.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: June 4, 2024
    Assignee: Annexon, Inc.
    Inventors: Ted Yednock, Sethu Sankaranarayanan, Michael Leviten, Arnon Rosenthal
  • ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
    Publication number: 20240083987
    Abstract: The present invention provides anti-C1q antibodies and methods of using the same.
    Type: Application
    Filed: February 16, 2023
    Publication date: March 14, 2024
    Inventors: Arnon Rosenthal, Michael Leviten
  • HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
    Publication number: 20240025974
    Abstract: The present disclosure is directed to humanized anti-C1q antibodies and methods of using them.
    Type: Application
    Filed: January 24, 2023
    Publication date: January 25, 2024
    Inventors: Arnon Rosenthal, Michael Leviten
  • Anti-complement factor C1Q antibodies and uses thereof
    Patent number: 11649279
    Abstract: The present invention provides anti-C1q antibodies and methods of using the same.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: May 16, 2023
    Assignee: Annexon, Inc.
    Inventors: Arnon Rosenthal, Michael Leviten
  • ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
    Publication number: 20210277096
    Abstract: The present invention provides anti-C1q antibodies and methods of using the same.
    Type: Application
    Filed: February 10, 2021
    Publication date: September 9, 2021
    Inventors: Arnon Rosenthal, Michael Leviten
  • HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
    Publication number: 20210115119
    Abstract: The present disclosure is directed to humanized anti-C1q antibodies and methods of using them.
    Type: Application
    Filed: April 8, 2020
    Publication date: April 22, 2021
    Inventors: Arnon Rosenthal, Michael Leviten
  • Anti-complement factor C1Q antibodies and uses thereof
    Patent number: 10927167
    Abstract: The present invention provides anti-C1q antibodies and methods of using the same.
    Type: Grant
    Filed: February 6, 2020
    Date of Patent: February 23, 2021
    Assignee: Annexon, Inc.
    Inventors: Arnon Rosenthal, Michael Leviten
  • ANTI-COMPLEMENT FACTOR C1Q FAB FRAGMENTS AND USES THEREOF
    Publication number: 20200317765
    Abstract: The present disclosure relates generally to anti-C1q antibody Fab fragments and methods of using the same.
    Type: Application
    Filed: June 25, 2020
    Publication date: October 8, 2020
    Inventors: Ted Yednock, Sethu Sankaranarayanan, Michael Leviten, Arnon Rosenthal
  • ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
    Publication number: 20200239557
    Abstract: The present invention provides anti-C1q antibodies and methods of using the same.
    Type: Application
    Filed: February 6, 2020
    Publication date: July 30, 2020
    Inventors: Arnon Rosenthal, Michael Leviten
  • Anti-complement factor C1q Fab fragments and uses thereof
    Patent number: 10723788
    Abstract: The present disclosure relates generally to anti-C1q antibody Fab fragments and methods of using the same.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: July 28, 2020
    Assignee: Annexon, Inc.
    Inventors: Ted Yednock, Sethu Sankaranarayanan, Michael Leviten, Arnon Rosenthal
  • Anti-complement factor C1q antibodies and uses thereof
    Patent number: 10590190
    Abstract: The present invention provides anti-C1q antibodies and methods of using the same.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: March 17, 2020
    Assignee: Annexon, Inc.
    Inventors: Arnon Rosenthal, Michael Leviten
  • HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
    Publication number: 20190315845
    Abstract: The present disclosure is directed to humanized anti-C1q antibodies and methods of using them.
    Type: Application
    Filed: May 17, 2019
    Publication date: October 17, 2019
    Inventors: Arnon Rosenthal, Michael Leviten
  • ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
    Publication number: 20190211084
    Abstract: The present invention provides anti-C1q antibodies and methods of using the same.
    Type: Application
    Filed: January 4, 2019
    Publication date: July 11, 2019
    Inventors: Arnon Rosenthal, Michael Leviten
  • Humanized anti-complement factor C1Q antibodies
    Patent number: 10316081
    Abstract: The present disclosure is directed to humanized anti-C1q antibodies and methods of using them.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: June 11, 2019
    Assignee: Annexon, Inc.
    Inventors: Arnon Rosenthal, Michael Leviten
  • Anti-complement factor C1q antibodies and uses thereof
    Patent number: 10227398
    Abstract: The present invention provides anti-C1q antibodies and methods of using the same.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: March 12, 2019
    Assignee: Annexon, Inc.
    Inventors: Arnon Rosenthal, Michael Leviten
  • COMPOSITIONS AND METHODS FOR TREATMENT OF INSULIN-DEPENDENT DIABETES MELLITUS
    Publication number: 20180092991
    Abstract: This invention provides methods of treating insulin-dependent diabetes mellitus in a subject comprising administering to the subject a self-vector encoding human proinsulin. The invention also provides a pharmaceutical composition comprising a self-vector encoding human proinsulin, as well as treatment and maintenance regimens for administering the pharmaceutical composition to a subject.
    Type: Application
    Filed: June 7, 2010
    Publication date: April 5, 2018
    Applicant: BAYHILL THERAPEUTICS, INC.
    Inventors: Hideki Garren, Michael Leviten, Nanette Solvason
  • ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
    Publication number: 20170334976
    Abstract: The present invention provides anti-C1q antibodies and methods of using the same.
    Type: Application
    Filed: April 19, 2017
    Publication date: November 23, 2017
    Inventors: Arnon Rosenthal, Michael Leviten
  • Anti-complement factor C1q antibodies and uses thereof
    Patent number: 9708394
    Abstract: The present invention provides anti-C1q antibodies and methods of using the same.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: July 18, 2017
    Assignee: Annexon, Inc.
    Inventors: Arnon Rosenthal, Michael Leviten
  • ANTI-COMPLEMENT FACTOR C1Q FAB FRAGMENTS AND USES THEREOF
    Publication number: 20170152309
    Abstract: The present disclosure relates generally to anti-C1q antibody Fab fragments and methods of using the same.
    Type: Application
    Filed: November 23, 2016
    Publication date: June 1, 2017
    Applicant: Annexon, Inc.
    Inventors: Ted Yednock, Sethu Sankaranarayanan, Michael Leviten, Arnon Rosenthal
  • METHODS FOR SCREENING FOR INHIBITORS OF COMPLEMENT SERINE PROTEASES
    Publication number: 20170081700
    Abstract: The present disclosure relates to methods for screening for inhibitors of complement serine proteases by measuring the interaction of a serine protease with a molecular probe in the presence and absence of test compounds.
    Type: Application
    Filed: March 19, 2015
    Publication date: March 23, 2017
    Inventors: Arnon Rosenthal, Michael Leviten